on Nanohale AG (isin : DE000A1EWVY8)
Formycon Joins TecDAX Index
Formycon AG, a prominent biosimilar developer, is set to be included in the TecDAX Index of Deutsche Börse, effective January 13, 2025. This aligns Formycon with the top 30 technology firms in Germany based on market capitalization and trading volume. The move follows the company's recent listing in the SDAX and Prime Standard, enhancing its market position and visibility.
Enno Spillner, CFO of Formycon, highlighted the inclusion as a testament to the company’s strategic focus and the team’s performance. Since its initial public offering in 2010, the company has aligned with market demands, achieving significant business growth, particularly marked by its uplisting in November 2024.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Nanohale AG news